1. Home
  2. AMPH vs EXG Comparison

AMPH vs EXG Comparison

Compare AMPH & EXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • EXG
  • Stock Information
  • Founded
  • AMPH 1996
  • EXG 2007
  • Country
  • AMPH United States
  • EXG United States
  • Employees
  • AMPH N/A
  • EXG N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • EXG Finance Companies
  • Sector
  • AMPH Health Care
  • EXG Finance
  • Exchange
  • AMPH Nasdaq
  • EXG Nasdaq
  • Market Cap
  • AMPH 2.5B
  • EXG 2.5B
  • IPO Year
  • AMPH 2014
  • EXG N/A
  • Fundamental
  • Price
  • AMPH $44.55
  • EXG $8.38
  • Analyst Decision
  • AMPH Buy
  • EXG
  • Analyst Count
  • AMPH 4
  • EXG 0
  • Target Price
  • AMPH $63.00
  • EXG N/A
  • AVG Volume (30 Days)
  • AMPH 404.9K
  • EXG 533.2K
  • Earning Date
  • AMPH 11-06-2024
  • EXG 01-01-0001
  • Dividend Yield
  • AMPH N/A
  • EXG 8.27%
  • EPS Growth
  • AMPH 17.38
  • EXG N/A
  • EPS
  • AMPH 3.01
  • EXG N/A
  • Revenue
  • AMPH $723,549,000.00
  • EXG N/A
  • Revenue This Year
  • AMPH $17.23
  • EXG N/A
  • Revenue Next Year
  • AMPH $10.25
  • EXG N/A
  • P/E Ratio
  • AMPH $14.78
  • EXG N/A
  • Revenue Growth
  • AMPH 20.33
  • EXG N/A
  • 52 Week Low
  • AMPH $36.56
  • EXG $6.78
  • 52 Week High
  • AMPH $65.92
  • EXG $8.15
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 38.65
  • EXG 43.69
  • Support Level
  • AMPH $43.09
  • EXG $8.31
  • Resistance Level
  • AMPH $49.53
  • EXG $8.51
  • Average True Range (ATR)
  • AMPH 1.76
  • EXG 0.12
  • MACD
  • AMPH -0.62
  • EXG -0.01
  • Stochastic Oscillator
  • AMPH 13.43
  • EXG 18.06

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks with an emphasis on dividend-paying stocks and writes call options on one or more U.S. and foreign indices with respect to a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.

Share on Social Networks: